MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
95 hedge funds and large institutions have $200M invested in Merrimack Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 43 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
35% less capital invested
Capital invested by funds: $310M → $200M (-$110M)
Holders
95
Holding in Top 10
–
Calls
$213K
Puts
$239K
Top Buyers
| 1 | +$8.78M | |
| 2 | +$5.12M | |
| 3 | +$3.56M | |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.42M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.09M |
Top Sellers
| 1 | -$5.66M | |
| 2 | -$5.28M | |
| 3 | -$3.22M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.3M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.09M |